홍태희 (연세대학교 의과대학, 세브란스병원)님 | 한빛사연구자 > 한빛사

연세대학교 의과대학, 세브란스병원

최종업데이트 2024.07.10.

Clinical Utility of Tumor-Naïve Pre-surgical ctDNA Detection in Early-stage NSCLC
- J. Thorac. Oncol., Available online 9 July 2024 | https://doi.org/10.1016/j.jtho.2024.07.002
- 2024-07
- 의약학
- 한빛사논문
Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer
- EBioMedicine, Volume 102, April 2024, 105062 | https://doi.org/10.1016/j.ebiom.2024.105062
- 2024-04
- 의약학
- 한빛사논문
Clinical significance of IASLC proposed pathologic criteria for invasion in resected non-mucinous lung adenocarcinoma
- J. Thorac. Oncol., Oct 23 2023, S1556-0864(23)02311-0 | https://doi.org/10.1016/j.jtho.2023.10.013
- 2023-10
- 의약학
- 한빛사논문
Programmed Death-Ligand 1 Copy Number Alteration as an Adjunct Biomarker of Response to Immunotherapy in Advanced Non-small Cell Lung Cancer
- J. Thorac. Oncol., Published: April 05, 2023 | https://doi.org/10.1016/j.jtho.2023.03.024
- 2023-04
- 의약학
- 한빛사논문
Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity
- J. Immunother. Cancer, First published October 19, 2020, 8:e001199 | doi: 10.1136/jitc-2020-001199
- 2020-10
- 의약학
- 한빛사논문

연구자 ID

저자논문